While CXCR4 is present in almost all invasive cancers, CXCR5 has been implicated in advanced stages of chronic myelogenous leukemia, head and neck cancers, colon, and prostate cancer [1,12,29,50]. This evidence concerns the gene CXCR4 and prostate cancer.